Oxidized low-density lipoprotein increases osteopontin expression by generation of oxidative stress

Free Radical Biology and Medicine

Volumn 48, Issue 10, 2010, Pages 1382-1387

  Mazière, Cécile ^a,b,c   Gomila, Cathy ^a,b,c   Mazière, Jean Claude ^a,b,c  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^c INSERM   (France)

Author keywords

Atherosclerosis; Free radicals; Inflammation; Osteopontin; Oxidative stress; Oxidized LDL

Indexed keywords

ALPHA TOCOPHEROL; BUTHIONINE SULFOXIMINE; HYDROGEN PEROXIDE; LIPID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOPONTIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN KINASE INHIBITOR; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE COURSE; EMBRYO; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; KERATINOCYTE; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SMOOTH MUSCLE FIBER; TIME; ULTRAVIOLET A RADIATION;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; BUTHIONINE SULFOXIMINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HYDROGEN PEROXIDE; INFLAMMATION MEDIATORS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MAP KINASE KINASE 4; MYOCYTES, SMOOTH MUSCLE; OSTEOPONTIN; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; REACTIVE OXYGEN SPECIES; TOCOPHEROLS; ULTRAVIOLET RAYS;

RATTUS;

EID: 77951938747     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.02.022     Document Type: Article

References (38)

1. Steinberg D. Hypercholesterolemia and inflammation in atherogenesis: two sides of the same coin. Mol. Nutr. Food Res. 2005, 49:995-998.
2. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
3. Jara L.J., Medina G., Vera-Lastra O., Amigo M.C. Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases. Autoimmun. Rev. 2006, 5:195-201.
4. Liuzzo G., Giubilato G., Pinnelli M. T cells and cytokines in atherogenesis. Lupus 2005, 14:732-735.
5. Patarca R., Freeman G.J., Singh R.P., Wei F.Y., Durfee T., Blattner F., Regnier D.C., Kozak C.A., Mock B.A., Morse H.C. Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene: definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J. Exp. Med. 1989, 170:145-161.
6. Nagai S., Hashimoto S., Yamashita T., Toyoda N., Satoh T., Suzuki T., Matsushima K. Comprehensive gene expression profile of human activated T(h)1- and T(h)2-polarized cells. Int. Immunol. 2001, 13:367-376.
7. Nagasaka A., Matsue H., Matsushima H., Aoki R., Nakamura Y., Kambe N., Kon S., Uede T., Shimada S. Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur. J. Immunol. 2008, 38:489-499.
8. Giachelli C.M., Lombardi D., Johnson R.J., Murry C.E., Almeida M. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am. J. Pathol. 1998, 152:353-358.
9. Weber G.F., Zawaideh S., Hikita S., Kumar V.A., Cantor H., Ashkar S. Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J. Leukocyte Biol. 2002, 72:752-761.
10. Koh A., da Silva A.P., Bansal A.K., Bansal M., Sun C., Lee H., Glogauer M., Sodek J., Zohar R. Role of osteopontin in neutrophil function. Immunology 2007, 122:466-475.
11. Singh M., Ananthula S., Milhorn D.M., Krishnaswamy G., Singh K. Osteopontin: a novel inflammatory mediator of cardiovascular disease. Front. Biosci. 2007, 12:214-221.
12. Nomiyama T., Perez-Tilve D., Ogawa D., Gizard F., Zhao Y., Heywood E.B., Jones K.L., Kawamori R., Cassis L.A., Tschöp M.H., Bruemmer D. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J. Clin. Invest. 2007, 117:2877-2888.
13. Scatena M., Liaw L., Giachelli C.M. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2302-2309.
14. Xie Z., Singh M., Singh K. Osteopontin modulates myocardial hypertrophy in response to chronic pressure overload in mice. Hypertension 2004, 44:826-831.
15. Soejima H., Irie A., Fukunaga T., Oe Y., Kojima S., Kaikita K., Kawano H., Sugiyama S., Yoshimura M., Kishikawa H., Nishimura Y., Ogawa H. Osteopontin expression of circulating T cells and plasma osteopontin levels are increased in relation to severity of heart failure. Circ. J. 2007, 71:1879-1884.
16. Matsui Y., Jia N., Okamoto H., Kon S., Onozuka H., Akino M., Liu L., Morimoto J., Rittling S.R., Denhardt D., Kitabatake A., Uede T. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy. Hypertension 2004, 43:1195-1201.
17. Ikeda T., Shirasawa T., Esaki Y., Yoshiki S., Hirokawa K. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J. Clin. Invest. 1993, 92:2814-2820.
18. Kurata M., Okura T., Watanabe S., Fukuoka T., Higaki J. Osteopontin and carotid atherosclerosis in patients with essential hypertension. Clin. Sci. (London) 2006, 111:319-324.
19. Matsui Y., Rittling S.R., Okamoto H., Inobe M., Jia N., Shimizu T., Akino M., Sugawara T., Morimoto J., Kimura C., Kon S., Denhardt D., Kitabatake A., Uede T. Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1029-1034.
20. Chiba S., Okamoto H., Kon S., Kimura C., Murakami M., Inobe M., Matsui Y., Sugawara T., Shimizu T., Uede T., Kitabatake A. Development of atherosclerosis in osteopontin transgenic mice. Heart Vessels 2002, 16:111-117.
21. Isoda K., Kamezawa Y., Ayaori M., Kusuhara M., Tada N., Ohsuzu F. Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions. Circulation 2003, 107:679-681.
22. Havel R.J., Eden H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1955, 34:1345-1353.
23. Yagi K. Lipid peroxide and human diseases. Chem. Phys. Lipids 1987, 45:337-351.
24. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959, 37:911-917.
25. Scott J.A., Homcy C.J., Khaw B.A., Rabito C.A. Quantitation of intracellular oxidation in a renal epithelial cell line. Free Radic. Biol. Med. 1988, 4:79-83.
26. Augé N., Escargueil-Blanc I., Lajoie-Mazenc I., Suc I., Andrieu-Abadie N., Pieraggi M.T., Chatelut M., Thiers J.C., Jaffrézou J.P., Laurent G., Levade T., Nègre-Salvayre A., Salvayre R. Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein. J. Biol. Chem. 1998, 273:12893-12900.
27. Schroeter H., Spencer J.P., Rice-Evans C., Williams R.J. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem. J. 2001, 358:547-557.
28. Jing Q., Xin S.M., Cheng Z.J., Zhang W.B., Zhang R., Qin Y.W., Pei G. Activation of p38 mitogen-activated protein kinase by oxidized LDL in vascular smooth muscle cells: mediation via pertussis toxin-sensitive G proteins and association with oxidized LDL-induced cytotoxicity. Circ. Res. 1999, 84:831-839.
29. San Martín A., Du P., Dikalova A., Lassègue B., Aleman M., Góngora M.C., Brown K., Joseph G., Harrison D.G., Taylor W.R., Jo H., Griendling K.K. Reactive oxygen species-selective regulation of aortic inflammatory gene expression in type 2 diabetes. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H2073-H2082.
30. Xie Z., Singh M., Singh K. ERK1/2 and JNKs, but not p38 kinase, are involved in reactive oxygen species-mediated induction of osteopontin gene expression by angiotensin II and interleukin-1beta in adult rat cardiac fibroblasts. J. Cell. Physiol. 2004, 198:399-407.
31. Renault M.A., Jalvy S., Potier M., Belloc I., Genot E., Dekker L.V., Desgranges C., Gadeau A.P. UTP induces osteopontin expression through a coordinate action of NFkappaB, activator protein-1, and upstream stimulatory factor in arterial smooth muscle cells. J. Biol. Chem. 2005, 280:2708-2713.
32. Mazière C., Djavaheri-Mergny M., Frey-Fressart V., Delattre J., Mazière J.C. Copper and cell-oxidized low-density lipoprotein induces activator protein 1 in fibroblasts, endothelial and smooth muscle cells. FEBS Lett. 1997, 409:351-356.
33. Mazière C., Auclair M., Djavaheri-Mergny M., Packer L., Mazière J.C. Oxidized low density lipoprotein induces activation of the transcription factor NF kappa B in fibroblasts, endothelial and smooth muscle cells. Biochem. Mol. Biol. Int. 1996, 39:1201-1207.
34. Hsieh C.C., Yen M.H., Yen C.H., Lau Y.T. Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells. Cardiovasc. Res. 2001, 49:135-145.
35. Lizard G., Gueldry S., Sordet O., Monier S., Athias A., Miguet C., Bessede G., Lemaire S., Solary E., Gambert P. Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J. 1998, 12:1651-1663.
36. Li T., Liu G.L., Duan M.X., Liu J.Y. Radish phospholipid hydroperoxide glutathione peroxidase provides protection against hydroperoxide-mediated injury in mouse 3T3 fibroblasts. BMB Rep. 2009, 42:648-654.
37. Nakamura K., Miura D., Kusano K.F., Fujimoto Y., Sumita-Yoshikawa W., Fuke S., Nishii N., Nagase S., Hata Y., Morita H., Matsubara H., Ohe T., Ito H. 4-Hydroxy-2-nonenal induces calcium overload via the generation of reactive oxygen species in isolated rat cardiac myocytes. J. Card. Fail. 2009, 15:709-716.
38. San Martín A., Du P., Dikalova A., Lassègue B., Aleman M., Góngora M.C., Brown K., Joseph G., Harrison D.G., Taylor W.R., Jo H., Griendling K.K. Reactive oxygen species-selective regulation of aortic inflammatory gene expression in type 2 diabetes. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H2073-H2082.